Clinical Trial

Randomized, Double-blind Crossover Trial Comparing Low-GI Functional vs. Standard Wholegrain Carbohydrates on Glycolipid Metabolism and Vascular Stress Markers in Adults With Suboptimal Triglyceridemia

Study acronym: GLOW
Recruiting
View on ClinicalTrials.gov →
Summary
Low-glycemic index (GI) carbohydrates help prevent type 2 diabetes and cardiovascular disease by reducing postprandial glucose, insulin spikes, inflammation, and triglyceride synthesis. They improve weight, lipid profiles, and vascular health. Our study will compare functional low-GI vs. standard wholegrain carbs in a Mediterranean diet to assess their effect on the Triglycerides-Glucose Index, a marker of metabolic and cardiovascular risk, in subjects with suboptimal triglyceride levels.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-21.
Status change: Not Yet Recruiting → Recruiting 2026-04-27
Trial Details
NCT Number NCT07198789
Lead Sponsor University of Bologna
Conditions Cardiovascular Prevention, Diabetes Prevention, Inflammation, Nutrition
Enrollment 40 participants
Start Date 2026-02-02
Primary Completion 2026-09-29 (estimated)
Study Completion 2026-09-29 (estimated)
Updated on ClinicalTrials.gov 2026-05-01